Elevated intraocular pressure (IOP) is an important risk factor for glaucoma. Mechanisms involved in its homeostasis are not well understood, but associations between metabolic factors and IOP have been reported. To investigate the relationship between levels of circulating metabolites and IOP, we performed a metabolome-wide association using a machine learning algorithm, and then employing Mendelian Randomization models to further explore the strength and directionality of effect of the metabolites on IOP. We show that O-methylascorbate, a circulating Vitamin C metabolite, has a significant IOP-lowering effect, consistent with previous knowledge of the anti-hypertensive and anti-oxidative role of ascorbate compounds. These results enhance understanding of IOP control and may potentially benefit future IOP treatment and reduce vision loss from glaucoma.

Ascorbic acid metabolites are involved in intraocular pressure control in the general population / P. Hysi, A. Khawaja, C. Menni, B. Tamraz, N. Wareha, K. Khaw, P. Foster, L. Benet, T. Spector, C. Hammond. - In: REDOX BIOLOGY. - ISSN 2213-2317. - 20:(2019), pp. 349-353. [10.1016/j.redox.2018.10.004]

Ascorbic acid metabolites are involved in intraocular pressure control in the general population

C. Menni;
2019

Abstract

Elevated intraocular pressure (IOP) is an important risk factor for glaucoma. Mechanisms involved in its homeostasis are not well understood, but associations between metabolic factors and IOP have been reported. To investigate the relationship between levels of circulating metabolites and IOP, we performed a metabolome-wide association using a machine learning algorithm, and then employing Mendelian Randomization models to further explore the strength and directionality of effect of the metabolites on IOP. We show that O-methylascorbate, a circulating Vitamin C metabolite, has a significant IOP-lowering effect, consistent with previous knowledge of the anti-hypertensive and anti-oxidative role of ascorbate compounds. These results enhance understanding of IOP control and may potentially benefit future IOP treatment and reduce vision loss from glaucoma.
Ascorbate metabolism; Intraocular pressure; Multi-omics
Settore MED/01 - Statistica Medica
2019
13-ott-2018
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S2213231718306839-main.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 468.7 kB
Formato Adobe PDF
468.7 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1094330
Citazioni
  • ???jsp.display-item.citation.pmc??? 21
  • Scopus 36
  • ???jsp.display-item.citation.isi??? 36
  • OpenAlex ND
social impact